Alejandro Dorenbaum

Alejandro Dorenbaum

Corporate Officer/Principal bij
Stanford University School of Medicine
66 jaar
Health Technology
Consumer Services

Profiel

Dr. Alejandro Dorenbaum, MD, is a Chief Medical Officer at Reneo Pharmaceuticals, Inc. and a Clinical Professor-Pediatrics at Stanford University School of Medicine.
Dr. Dorenbaum was previously employed as a Chief Medical Officer by Allakos, Inc., a Chief Medical Officer by Lumena Pharmaceuticals, Inc., a Medical Director by Genentech, Inc., a Senior Director-Clinical Affairs by BioMarin Pharmaceutical, Inc., a Director-Clinical Development by Chiron Corp., and an Assistant Clinical Professor-Pediatrics by The University of California, San Francisco.
He received his doctorate degree from Universidad Nacional Autónoma de México.

Actieve functies van Alejandro Dorenbaum

BedrijvenFunctieBegin
Corporate Officer/Principal -

Eerdere bekende functies van Alejandro Dorenbaum

BedrijvenFunctieEinde
ALLAKOS INC. Hoofd Techniek/Wetenschap/O&O 01-06-2017
Hoofd Techniek/Wetenschap/O&O 30-06-2014
BIOMARIN PHARMACEUTICAL INC. Hoofd Techniek/Wetenschap/O&O 01-01-2009
Corporate Officer/Principal 01-01-2003
Corporate Officer/Principal 01-01-2000
Ervaring van Alejandro Dorenbaum in detail bekijken

Opleiding van Alejandro Dorenbaum

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

70

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Beurs
  2. Insiders
  3. Alejandro Dorenbaum